巧特欣注射劑

Država: Tajvan

Jezik: kitajščina

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Prenos Navodilo za uporabo (PIL)
18-12-2020
Prenos Javno poročilo o oceni (PAR)
09-04-2020

Aktivna sestavina:

CARBETOCIN (ANHYDROUS ACETIC ACID FREE DEFINITION)

Dostopno od:

輝凌藥品股份有限公司 台北市中山區松江路111號11樓 (86386138)

Koda artikla:

H01BB03

Farmacevtska oblika:

注射液劑

Sestava:

CARBETOCIN (ANHYDROUS ACETIC ACID FREE DEFINITION) (7600001910) ug

Enote v paketu:

瓶裝

Razred:

製 劑

Tip zastaranja:

限由醫師使用

Izdeluje:

ZUELLIG PHARMA SPECIALTY SOLUTIONS GROUP PTE. LTD. 15 CHANGI NORTH WAY #01-02, #02-02, #02-10, SINGAPORE 498770 SG

Terapevtsko območje:

carbetocin

Terapevtske indikacije:

預防子宮收縮乏力造成的產後出血。

Povzetek izdelek:

有效日期: 2027/08/17; 英文品名: Duratocin Injection 100mcg/ml

Datum dovoljenje:

2012-08-17

Navodilo za uporabo

                                DURATOCIN
®
QUALITATIVE AND QUANTITATIVE COMPOSITION
Carbetocin 100 micrograms/ml.
For a full list of excipients, see section LIST OF EXCIPIENTS.
PHARMACEUTICAL DOSAGE FORM
Solution for injection.
A clear colourless solution.
CLINICAL PARTICULARS
Therapeutic indications
Prevention of postpartum haemorrhage due to uterine atony.
Posology and method of administration
Posology
Caesarean section under epidural or spinal anaesthesia:
Withdraw 1 ml of DURATOCIN
®
containing 100 micrograms carbetocin
and administer only by intravenous injection, under adequate medical
supervision in a hospital.
Vaginal delivery:
Withdraw 1 ml of DURATOCIN
®
containing 100 micrograms carbetocin
and administer by intravenous injection or intramuscular injection,
under
adequate medical supervision in a hospital.
Paediatric population
There is no relevant use of carbetocin in children below 12 years of
age.
The safety and efficacy of carbetocin in adolescents has not yet been
established.
Currently available data are described in section 5.1 but no
recommendation on a
posology can be made.
Method of administration
Carbetocin must only be administered after delivery of the infant, and
as soon as possible after delivery, preferably before the delivery of
the
placenta.
For intravenous administration carbetocin must be administered slowly,
over 1 minute.
DURATOCIN
®
is intended for single use only. No further doses of
carbetocin should be administered.
Contraindications
- Pregnancy and labour before delivery of the infant.
- Induction of labour.
- Serious cardiovascular disorders.
- Hypersensitivity to carbetocin, oxytocin or to any of the excipients
listed
in “LIST OF EXCIPIENTS”.
- Hepatic or renal disease.
- Epilepsy
Special warnings and precautions for use
Carbetocin is intended for use only at well equipped specialist
obstetrics
units with experienced and qualified staff available at all times.
The use of carbetocin at any stage before delivery of the infant is
not
appropriate because its uterotonic activity persists for several
ho
                                
                                Preberite celoten dokument
                                
                            

Opozorila o iskanju, povezana s tem izdelkom